PreprintCC BY-NC-NDbioRxiv
Neonatal T cell maternal microchimerism is common and associates with early pregnancy SARS2 vaccination
5 affiliations
- 1Center for Global Infectious Disease Research, Seattle Children’s Research Institute, Seattle, WA
- 2Institute for Public Health Genetics, University of Washington School of Public Health, Seattle, WA
- 3Department of Obstetrics & Gynecology, University of Washington School of Medicine, Seattle, WA
- 4Department of Pediatrics, University of Washington School of Medicine, Seattle, WA
- 5Department of Global Health, University of Washington, Seattle, WA
Abstract
The fetus acquires a graft of maternal cells in utero, known as maternal microchimerism (MMc), which may be enriched for T cells. However, little is known regarding the determinants of T cell trafficking into the fetus or regarding the prevalence of T cell MMc in healthy neonates. Using a closely followed cohort, we determined the association between maternal vaccination and acute infection and the detection of T cell MMc in cord blood, as measured using polymorphism-specific qPCR. We identified an association between early pregnancy SARS2 mRNA vaccination, a potent T cell stimulus, and increased detection of T cell MMc.
Related
- Prenatal immune priming to Plasmodium falciparum is characterized by multi-lineage T-cell responses that are influenced by maternal microchimerism and predict malaria outcomes
- Intranasal adenovirus type 5 influenza vaccination enhances milk antibody responses and passive transfer to neonatal ferrets
- Pregnancy Impacts Maternal Sleep: Focus on Kynurenine Pathway Activation in Female Rats
- Maternal gut microbiota, tryptophan metabolism and immune homeostasis: Implications for the prevention of adverse pregnancy complications
- From maternal microbial transmission to neonatal gut microbiota restoration: the potential and challenges of maternal fecal microbiota transplantation
BibTeX
@misc{weaver2026neonatal,
title = {{Neonatal T cell maternal microchimerism is common and associates with early pregnancy SARS2 vaccination}},
author = {Jacquelyn Weaver and John Houck and Yonghou Jiang and Cara Tobey and Jia Wong and Swati Shree and Whitney E Harrington},
howpublished = {bioRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.23.761412},
url = {https://www.biorxiv.org/content/10.64898/2026.10.23.761412v1},
note = {CC BY-NC-ND},
}
RIS
TY - UNPB
TI - Neonatal T cell maternal microchimerism is common and associates with early pregnancy SARS2 vaccination
AU - Jacquelyn Weaver
AU - John Houck
AU - Yonghou Jiang
AU - Cara Tobey
AU - Jia Wong
AU - Swati Shree
AU - Whitney E Harrington
PY - 2026
DA - 2026/10/23
PB - bioRxiv
DO - 10.64898/2026.10.23.761412
UR - https://www.biorxiv.org/content/10.64898/2026.10.23.761412v1
AB - The fetus acquires a graft of maternal cells in utero, known as maternal microchimerism (MMc), which may be enriched for T cells. However, little is known regarding the determinants of T cell trafficking into the fetus or regarding the prevalence of T cell MMc in healthy neonates. Using a closely followed cohort, we determined the association between maternal vaccination and acute infection and the detection of T cell MMc in cord blood, as measured using polymorphism-specific qPCR. We identified an association between early pregnancy SARS2 mRNA vaccination, a potent T cell stimulus, and increased detection of T cell MMc.
SN - 2692-8205
ER -